136 related articles for article (PubMed ID: 33797372)
1. Is Priapism a Common Presentation of Chronic Myeloid Leukemia in an Adolescent Patient?
Purohit AHL; Sarangi S; Kumar D; Bohra GK; Saha S; Pandey H
Cardiovasc Hematol Disord Drug Targets; 2021; 21(2):147-148. PubMed ID: 33797372
[TBL] [Abstract][Full Text] [Related]
2. Priapism as a result of chronic myeloid leukemia: case report, pathology, and review of the literature.
Shaeer OK; Shaeer KZ; AbdelRahman IF; El-Haddad MS; Selim OM
J Sex Med; 2015 Mar; 12(3):827-34. PubMed ID: 25630365
[TBL] [Abstract][Full Text] [Related]
3. Priapism as a Debut Presentation of Chronic Myeloid Leukemia.
Dhar J; Dhar J; Chhabra G; Khandelwal L; Khandelwal L; Batra A; Gupta N; Gupta N
J Coll Physicians Surg Pak; 2019 Jan; 29(1):78-80. PubMed ID: 30630577
[TBL] [Abstract][Full Text] [Related]
4. [Priapism as first clinical manifestation of chronic myeloid leucosis].
Rustamov MN; Huseynov GR; Ahmedov IS
Urologiia; 2019 Dec; (5):112-113. PubMed ID: 31808643
[TBL] [Abstract][Full Text] [Related]
5. Case 3: Priapism in a 13-year-old Boy.
Clark AJ; Hsu P; Darves-Bornoz A; Tanaka ST; Mason EF; Katzenstein HM
Pediatr Rev; 2018 Dec; 39(12):617-619. PubMed ID: 30504255
[No Abstract] [Full Text] [Related]
6. Priapismus as Leukostasis Manifestation in Chronic Myeloid Leukemia.
Rajabto W; Djianzonie JAC; Pratisthita LB; Shatri H
Acta Med Indones; 2020 Oct; 52(4):420-422. PubMed ID: 33377887
[TBL] [Abstract][Full Text] [Related]
7. Chronic myeloid leukaemia presenting as priapism: A case report from Khyber Pakhtunkhwa.
Khan A; Shafiq I; Shah MH; Khan S; Shahid G; Arabdin M
J Pak Med Assoc; 2018 Jun; 68(6):942-944. PubMed ID: 30323364
[TBL] [Abstract][Full Text] [Related]
8. How I manage priapism in chronic myeloid leukaemia patients.
Rodgers R; Latif Z; Copland M
Br J Haematol; 2012 Jul; 158(2):155-164. PubMed ID: 22571386
[TBL] [Abstract][Full Text] [Related]
9. [Priapism complicated by chronic myelogenous leukemia (CML); a case report].
Yoshida K; Kinoshita H; Taniguti H; Chizaki R; Nishida T; Kawakita S; Hiura Y; Ooguti N; Kawa G; Muguruma K; Matsuda T
Hinyokika Kiyo; 2007 May; 53(5):323-5. PubMed ID: 17561719
[TBL] [Abstract][Full Text] [Related]
10. Presence of novel compound BCR-ABL mutations in late chronic and advanced phase imatinib sensitive CML patients indicates their possible role in CML progression.
Akram AM; Iqbal Z; Akhtar T; Khalid AM; Sabar MF; Qazi MH; Aziz Z; Sajid N; Aleem A; Rasool M; Asif M; Aloraibi S; Aljamaan K; Iqbal M
Cancer Biol Ther; 2017 Apr; 18(4):214-221. PubMed ID: 28278078
[TBL] [Abstract][Full Text] [Related]
11. Priapism and chronic myeloid leukemia in an adolescent. Rare debut presentation. A case report.
Romero-Guerra AL; Salas-Cosio MJ; Bautista-Martínez BA; Castillo-Rodríguez SA; Landa Juárez S; Hernández-Piñon Z; Saldaña Sánchez IDR; Núñez-Enríquez JC
Arch Argent Pediatr; 2024 Apr; 122(2):e202310068. PubMed ID: 37871128
[TBL] [Abstract][Full Text] [Related]
12. [Imatinib is effective in a 12-month-old boy with chronic myelogenous leukemia: case report and literature review].
Pan Y; Wen S; Tian J; Lyu Z; Du Z; Yan L
Zhonghua Er Ke Za Zhi; 2015 Mar; 53(3):194-7. PubMed ID: 26165016
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of BCR-ABL T315I Mutation in Malaysian Patients with Imatinib-Resistant Chronic Myeloid Leukemia.
Mat Yusoff Y; Abu Seman Z; Othman N; Kamaluddin NR; Esa E; Zulkiply NA; Abdullah J; Zakaria Z
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3317-3320. PubMed ID: 30583336
[TBL] [Abstract][Full Text] [Related]
14. Reversal of Glanzmann thrombasthenia platelet phenotype after imatinib treatment in a pediatric chronic myeloid leukemia patient.
Chauhan R; Sazawal S; Singh K; Ragesh R Nair R; Chhikara S; Deka R; Chaubey R; Veetil KK; Dange P; Mahapatra M; Saxena R
Platelets; 2018 Mar; 29(2):203-206. PubMed ID: 29185819
[TBL] [Abstract][Full Text] [Related]
15. A rare presentation of chronic myeloid leukaemia with priapism treated with corporoglandular shunting.
Huei TJ; Lip HT; Shamsuddin O
Med J Malaysia; 2018 Dec; 73(6):420-422. PubMed ID: 30647220
[TBL] [Abstract][Full Text] [Related]
16. Priapism--a rare presentation in chronic myeloid leukemia: case report and review of the literature.
Chang MW; Tang CC; Chang SS
Chang Gung Med J; 2003 Apr; 26(4):288-92. PubMed ID: 12846529
[TBL] [Abstract][Full Text] [Related]
17. Priapism as a rare presentation of chronic myeloid leukemia.
Kumar P; Rahman K; Kumari S; Singh MK; Gupta R; Nityanand S
J Cancer Res Ther; 2018; 14(6):1442-1443. PubMed ID: 30488874
[No Abstract] [Full Text] [Related]
18. Newly diagnosed breast cancer in a patient receiving imatinib mesylate.
Kaygusuz-Atagunduz I; Toptas T; Yumuk F; Firatli-Tuglular T; Bayik M
J Cancer Res Ther; 2014; 10(4):1107-8. PubMed ID: 25579564
[TBL] [Abstract][Full Text] [Related]
19. Aberrant DNA methylation at HOXA4 and HOXA5 genes are associated with resistance to imatinib mesylate among chronic myeloid leukemia patients.
Elias MH; Azlan H; Sulong S; Baba AA; Ankathil R
Cancer Rep (Hoboken); 2018 Aug; 1(2):e1111. PubMed ID: 32721103
[TBL] [Abstract][Full Text] [Related]
20. Pattern of chronic myeloid leukemia in the imatinib era in a Sub-Saharan African setting.
Faye BF; Dieng N; Seck M; Gadji M; Gueye YB; Sy D; Toure SA; Sall A; Toure AO; Dieye TN; Diop S
Ann Hematol; 2016 Oct; 95(10):1603-10. PubMed ID: 27370991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
